The OBIO 2020 Niagara Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.
Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario
The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario’, which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
OBIO Announces Launch of OBIO CAAP® for 2019
The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2019 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s program.
OBIO Announces Successful 2019 Niagara Investment Summit
OBIO® (Ontario Bioscience Innovation Organization) is proud to announce the success of the 2019 Niagara Investment Summit on February 20-22, 2019. The 2019 Niagara Investment Summit featured over 30 of Canada’s most promising innovative health science companies and more than 30 US and global investors and VCs.
OBIO Opens 2019 Niagara Investment Summit, Connecting Canada’s Most Promising Innovations with Leading Global Investors
OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019. The 2019 Niagara Investment Summit will feature over 30 of Canada’s most promising innovative health science companies meeting with more than 30 US and global investors and VCs in Niagara-on-the-Lake to propel investment in Canada’s health science industry.
Ontario Bioscience Innovation Organization Announces a National Call to Companies for Applications for the 2019 Niagara Investment Summit
OBIO Completes Successful Canadian Health Investment Showcase in New York City
OBIO Opens Canadian Health Investment Showcase in New York City, Connecting Canada’s High Potential Health Science Companies with Premier US Investors
The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce the opening of the Canadian Health Investment Showcase in New York, NY, on November 5 and 6, 2018.
The Canadian Health Investment Showcase will feature 18 of Canada’s highest potential companies meeting with more than 35 US investors and VCs in New York City to drive investment in Canada’s health science industry.
OBIO is excited by the opportunities for investments and partnerships that the Canadian Health Investment Showcase will create. The overwhelming desire from both US investors and Canadian companies to be part of the Showcase ensures that this event will create unparalleled prospects for both North America’s premier private equity investors and Canada’s most promising health science companies.
Over two days at the Consulate General of Canada in New York, the Canadian Health Investment Showcase features hundreds of one-on-one meetings between companies and US investors, as well as panel discussions on cross-border investing in the health science industry and a keynote on trends in health investing this year.
Creating a dynamic environment for health science companies to meet with targeted US health investors is an opportunity not just for individual companies but the entire Canadian health science industry. I am not only pleased to join the delegation of companies at the Canadian Health Investment Showcase but also to congratulate OBIO on delivering an unprecedented event focused on the needs of Canadian companies.
To find out more, click here to read the full press release.
OBIO Launches 'Use It or Lose It', Latest Report on the Future of Canada’s Health Science Industry
The Ontario Bioscience Innovation Organization (OBIO®) released its latest report, ‘Use It or Lose It: Industry Solutions to Ontario’s Commercialization Gap’, with recommendations from health science company executives on how to create the conditions for the growth of Ontario’s health science industry.
Press Release: OBIO CAAP Companies Raise More Than $109 Million in Investments
Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit membership based organization that is Ontario’s leading advocate for the health science industry, announced today that Ontario health science companies that have participated in its Capital Access Advisory Program (CAAP®) have raised more than $109 Million since the CAAP program launched in 2013.
Ontario Bioscience Innovation Organization (OBIO®) Leadership Summit Hosts Top Health Science Minds to Define Future of the Industry
January 24, 2017 TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®) hosted a summit of industry, academic, government and investment leaders about the future of health science innovation in Canada. Attendees engaged in group discussions and heard from subject matter experts to extrapolate a mandate of action for anchoring health science companies in Ontario. The outcome of the summit lays a foundation for actionable business cases for private and public sector solutions to the health science industry’s biggest challenges: Innovation Pull, Adoption and Capital Attraction.
Versant Ventures Closes 6th Healthcare Fund
OBIO Announces New Public Relations & Communications Services Member Benefit
TORONTO, Dec. 7, 2016 - HOWE&WYE is proud to announce its new partnership with OBIO®. As a part of OBIO's new member benefit, HOWE&WYE will provide strategic public relations and communications services to OBIO's broad membership of world-class start-ups and bioscience companies. OBIO members will benefit from special access to top-tier agency support with optimized pricing to strengthen PR and marketing to fulfill strategic business outcomes for awareness, investment and commercialization.
OBIO® Launches the Health 2 Business Bridge Program™ H2BB™ Improving Access to Business Trained Talent in Ontario’s Health Science Industry
Toronto, Ontario, December 6, 2016 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit, membership based organization, that is Ontario’s leading advocate for the health science industry, hosted its Annual Public Meeting with the theme centered on “Bridging the Access to Talent Gap” at Norton Rose Fulbright LLP yesterday. The OBIO Annual Public Meeting provided a platform to highlight OBIO’s accomplishments made in 2016, upcoming initiatives for 2017 and an opportunity to hear from Parliamentary Assistant to the Minister of Economic Development and Growth, Cristina Martins and Members of the OBIO MPP Health Science Caucus, MPP Shafiq Qaadri and MPP Bill Walker, who welcomed networking with over 60 health science industry professionals.
The evening focused on a vision of collaboration across health science companies and highlighted the supportive partnership that the Province of Ontario has with OBIO. The evening also marked the launch of the OBIO Health to Business Bridge™ H2BB™ internship program. OBIO H2BB™ is a program in support of improving access to business trained talent in Ontario’s health science sector, ultimately contributing to a sustainable innovation economy.
The H2BB™ internship program will combine OBIO’s deep-rooted relationships across academia and industry to develop industry ready talent that strengthens business development capabilities in Ontario’s health science companies, and ultimately amplifies the innovation capability of the province.
OBIO’s ongoing dialogue with industry has identified access to industry ready business talent as a challenge for health science companies seeking to scale up and commercialize their technologies. The OBIO H2BB™ Program is intended to benefit all participants, interns and industry companies alike, to facilitate development of our knowledge economy and create leadership that understands emerging technology trends to ultimately achieve multipliers of job creation.
OBIO H2BB™ provides companies with a unique opportunity to access new talent, while assisting with critical business projects. Interns will rapidly develop knowledge and insight into new and ultimately profitable technologies.
Program Participation
Participation in OBIO H2BB™ is open to all Ontario companies developing health science products or services, who are interested in hiring a business trained intern to help complete a managerial project for a minimum duration of four-months. Interested companies are encouraged to contact OBIO to discuss their interest.
About OBIO
The Ontario Bioscience Innovation Organization (OBIO®) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario and one that will become a global leader in providing health technology products and services to the international marketplace. OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government.
For more information, visit the OBIO website www.obio.ca and follow OBIO on Twitter @OBIOscience.
OBIO Contacts
Eric Dolinar
Program Manager, Health to Business Bridge
ericdolinar@obio.ca
416-848-6839 ext. 107
Gail Garland
President and Chief Executive Officer, OBIO
gailgarland@obio.ca
416-848-6839 ext. 101
Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2017 Capital Access Advisory Program
OBIO Launches Report in the Nation’s Capital
OBIO Launches Provincewide Report Tour - First Stop: Silicon Valley North
June 8, 2016. Kitchener. Ontario Bioscience Innovation Organization (OBIO®) today initiated the first leg of its Provincewide Tour to promote their recently released report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy”.
For the full press release, click here
OBIO Hosts Annual Celebration of the Health Sciences Industry in Canada
Toronto, Ontario – May 5, 2016: Ontario Bioscience Innovation Organization (OBIO®) welcomed a prestigious group of investors, companies, MPPs and industry supporters to an intimate dinner on May 3 2016 in celebration of Canada’s health science industry. The event was supported by Torys LLP and by Bloom Burton & Co.
OBIO Launches Report on Building Canada’s Health Science Industry of the Future
Toronto, Ontario – April 29, 2016: Ontario Bioscience Innovation Organization (OBIO®) today released its report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy”. The report is the output of interviews and surveys of 125 CEOs of Canada’s health science companies looking at the future of the global industry and opportunities for Ontario and Canada.